Khajeelak Chiablaem


khajeelak
Name: Khajeelak Chiablaem

Office address: : B705C (office C), 7th Floor, Biomedical Science Building
54 Kamphaeng Phet 6 Talat Bang Khen, Lak Si, Bangkok 10210, Thailand
Tel: +66 25530 8555 (ext. 8355 )
E-mail: khajeelak 

Research Scientist

Research Interests
Cancer Biology, Herbal Medicine, Drug Delivery

Education
– B.Sc. Biology, Chiang Mai University, Chiang Mai, Thailand
– M.Sc. Technoprenership and Innovation Management, Chulalongkorn University, Bangkok, Thailand

Publications
– Chiablaem K, Lirdprapamongkol K, Keeratichamroen S, Surarit R, Svasti J. Curcumin Suppresses Vasculogenic Mimicry Capacity of Hepatocellular Carcinoma Cells through STAT3 and PI3K/AKT Inhibition. Anticacner Res 2014; 34: 1857-64.
– Amornwachirabodee K, Chiablaem K, Wacharasindhu S, Lirdprapamongkol K, Svasti J, Vchirawongkwin V, and Wanichwecharungruang SP. Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment. J Pharm Sci 2012; 101: 3779-3786.
– Weeraphan C, Diskul-Na-Ayudthaya P, Chiablaem K, Khongmanee A, Chokchaichamnankit D, Subhasitanont P, Svasti J, and Srisomsap C. Effective enrichment of cholangiocarcinoma secretomes using the hollow fiber bioreactor culture system. Talanta 2012; 99: 294-301.
– Lirdprapamongkol K, Chiablaem K, Sila-Asna M, Surarit R, Bunyaratvej A, and Svasti J. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2012; 422: 429-435.
– Thetsrimuang C, Khammuang S, Chiablaem K, Srisomsap C, Sarnthima R. Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév. Food Chem 2011; 128(3): 634-639.
– Suwannateep N, Banlunara W, Wanichwecharungruang SP, Chiablaem K, Lirdprapamongkol K, Svasti J. Mucoadhesive curcumin nanospheres: Biological activity, adhesion to stomach mucosa and release of curcumin into the circulation. J Control Release 2011; 151(2): 176-182.
– Pruksakorn D, Lirdprapamongkol K, Chokchaichamnankit D, Subhasitanont P, Chiablaem K, Svasti J, Srisomsap C. Metabolic alteration of HepG2 in scaffold-based 3-D culture: proteomic approach. Proteomics 2010.10(21): 3896-3904.
– Srisomsap C, Sawangareetrakul P, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Bhudhisawasdi V, Wongkham S, Svasti J. Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J Biomed Biotechnol 2010; Article ID 437143, 18 pages.
– Rubporn A, Srisomsap C, Subhasitanont P, Chokchaichamnankit D, Chiablaem K, Svasti J, Sangvanich P. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics 2009; 6: 229-237.
– Srisomsap C, Subhasitanont P, Sawangareetrakul P, Chokchaichamnankit D, Chiablaem K, and Svasti J. Identification of Potential Biomarkers to Differentiate Human Cholangiocarcinoma and Hepatocellular Carcinoma from Cell Lines. Anticancer Research 2008; 28: 3495-3496.
– Srisomsap C, Subhasitanont P, Sawangareetrakul P, Chokchaichamnankit D, Ngiwsara L, Chiablaem K, Svasti J. Comparison of membrane-associated proteins in human cholangiocarcinoma and hepatocellular carcinoma cell lines. Proteomics Clin Appl.2007; 1(1): 89-106.

 

Leave a Reply

Your email address will not be published. Required fields are marked *